Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Epilepsy Behav. 2020 Nov 24;114(Pt A):107543. doi: 10.1016/j.yebeh.2020.107543

Table 2.

Current and past psychiatric treatment in the sample

Treatment Modality/Agent (N=63 unless otherwise noted) Current N (%) Past N (%)
Psychiatrist visits 10 (15.9%) 31 (49.2%)
Counseling/psychotherapy 10 (15.9%) 33 (52.4%)
Medication prescribed by primary care physician (PCP) 23 (36.5%) 23 (36.5%)
Medication prescribed by neurologist 35 (55.6%) 11 (17.5%)
Medication prescribed by other physician specialty 10 (15.9%) 14 (22.2%)
Treatment by a nurse practitioner or physician assistant 7 (11.1%) 14 (22.2%)
Complementary/alternative therapies (eg. yoga, relaxation) 10 (15.9%) 18 (28.6%)
Other treatmentsa 3 (4.8%) 7 (11.1%)
Psychiatric hospitalization N/A 19 (30.2%)
Psychotropic medications overall 44 (69.8%) 55 (87.3%)
 Antidepressants 36 (57.1%) 48/62 (77.4%)
  sertraline 7 (11.1%) 19/62 (30.6%)
  escitalopram 11 (17.5%) 16/62 (25.8%)
  citalopram 5 (7.9%) 12/62 (19.4%)
  fluoxetine 4 (6.3%) 20/62 (32.3%)
 Other anxiolytics for anxiety symptoms 21 (33.3%) 27 (42.9%)
  alprazolam 3 (4.8%) 15 (23.8%)
  clonazepam 10 (15.9%) 16 (25.4%)
  lorazepam 4 (6.3%) 9 (14.3%)
  hydroxyzine 4 (6.3%) 5 (7.9%)
 Atypical antipsychotics 9 (14.3%) 11 (17.5%)
 Lithium 0 (0.0%) 2 (3.2%)
 Mood stabilizing antiseizure medication solely for mood N/A 17/ 61 (27.9%)
Psychotropic medication adherence (Morisky Scale) N=42 N/A
 forget to take it 13/ 42 (31.0%)
 careless about taking it 5/ 42 (11.9%)
 stop it when feeling better 3/ 42 (7.1%)
 stop it if feel worse when taking it 2/ 42 (4.8%)
a

other treatments reported by participants included: work and soccer, though most who reported “other” treatment type did not respond to the question about the specific type of other treatment.